Stock Quote        
  Join        Login  
logo

Mantech (MANT) JV Receives Contract to Support Marine Corps Warfighting Laboratory

 November 30, 2012 10:36 AM
 

(By Balaseshan) ManTech International Corp. (NASDAQ: MANT) said its joint venture team received a contract worth $23 million to support the Marine Corps Warfighting Laboratory.

Marine Corps Base Quantico – National Capital Region (RCO-NCR) awarded the joint venture team of ManTech and Genex Systems LLC, dubbed GenTech partners, a prime contract.

GenTech Partners will provide the Marine Corps Warfighting Laboratory (MCWL) with a full range of engineering, analytical, technical, and business services. The MCWL works closely with the Office of Naval Research and the Defense Advanced Research Projects Agency.

The MCWL was established in 1995 with the mandate to develop the future vision and map the future capabilities for the Marine Corps as an integral part of the combat development process.

"The Marine Corps Warfighting Laboratory plays an important role in the technological advancement of Marine Corps capabilities. We have established a strong working relationship with our joint venture partner, Genex, and we look forward to contributing to the continued effectiveness of the Marine Corps warfighter," said Louis Addeo, president and chief operating officer of ManTech's Technical Services Group.

ManTech is a provider of technologies and solutions for mission-critical national security programs for the intelligence community; Departments of Defense (DOD), state, homeland security, energy and justice, including the Federal Bureau of Investigations (FBI); the space community, and other United States federal government customers

MANT is trading up 0.08 percent at $25.52 on Friday. The stock has been trading between $19.74 and $37.16 for the past 52 weeks.


Rich
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.

You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.

Two Week FREE Trial


Signup for i on the market daily edition


Advertisement

Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

Advertisement
Connect with iStockAnalyst
Popular Articles
Recent Research and Quote
Advertisement
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.